Unknown

Dataset Information

0

Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.


ABSTRACT: Thrombopoietin receptor agonists (TPO-RAs) are used as effective alternative treatments in ITP patients unresponsive to first-/second-line therapies. TPO-RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsive patients, TPO-RAs can be suspended maintaining a sustained response.

SUBMITTER: Santoro C 

PROVIDER: S-EPMC5538052 | biostudies-other | 2017 Aug

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC8362082 | biostudies-literature
| S-EPMC6590510 | biostudies-literature
| S-EPMC3350461 | biostudies-other
| S-EPMC4580983 | biostudies-literature
| S-EPMC6288500 | biostudies-other
| S-EPMC7342684 | biostudies-literature
| S-EPMC6733339 | biostudies-literature
| S-EPMC7874092 | biostudies-literature
| S-EPMC4309514 | biostudies-literature
| S-EPMC6115534 | biostudies-literature